The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Citalopram versus other anti-depressive agents for depression
Open accessAbstract
BACKGROUND: Recent US and UK clinical practice guidelines recommend that second-generation antidepressants should be considered amongst the best first-line options when drug therapy is indicated for a depressive episode. Systematic reviews have already highlighted some differences in efficacy between second-generation antidepressants. Citalopram, one of the first selective serotonin reuptake inhibitors (SSRI) introduced in the market, is one of these antidepressant drugs that clinicians use for routine depression care. OBJECTIVES: To assess the evidence for the efficacy, acceptability and tolerability of citalopram in comparison with tricyclics, heterocyclics, other SSRIs and other conventional and non-conventional antidepressants in the acute-phase treatment of major depression. SEARCH METHODS: We searched The Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register and the Cochrane Central Register of Controlled Trials up to February 2012. No language restriction was applied. We contacted pharmaceutical companies and experts in this field for supplemental data. SELECTION CRITERIA: Randomised controlled trials allocating patients with major depression to citalopram versus any other antidepressants. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data. Information extracted included study characteristics, participant characteristics, intervention details and outcome measures in terms of efficacy (the number of patients who responded or remitted), patient acceptability (the number of patients who failed to complete the study) and tolerability (side-effects). MAIN RESULTS: Thirty-seven trials compared citalopram with other antidepressants (such as tricyclics, heterocyclics, SSRIs and other antidepressants, either conventional ones, such as mirtazapine, venlafaxine and reboxetine, or non-conventional, like hypericum). Citalopram was shown to be significantly less effective than escitalopram in achieving acute response (odds ratio (OR) 1.47, 95% confidence interval (CI) 1.08 to 2.02), but more effective than paroxetine (OR 0.65, 95% CI 0.44 to 0.96) and reboxetine (OR 0.63, 95% CI 0.43 to 0.91). Significantly fewer patients allocated to citalopram withdrew from trials due to adverse events compared with patients allocated to tricyclics (OR 0.54, 95% CI 0.38 to 0.78) and fewer patients allocated to citalopram reported at least one side effect than reboxetine or venlafaxine (OR 0.64, 95% CI 0.42 to 0.97 and OR 0.46, 95% CI 0.24 to 0.88, respectively). AUTHORS' CONCLUSIONS: Some statistically significant differences between citalopram and other antidepressants for the acute phase treatment of major depression were found in terms of efficacy, tolerability and acceptability. Citalopram was more efficacious than paroxetine and reboxetine and more acceptable than tricyclics, reboxetine and venlafaxine, however, it seemed to be less efficacious than escitalopram. As with most systematic reviews in psychopharmacology, the potential for overestimation of treatment effect due to sponsorship bias and publication bias should be borne in mind when interpreting review findings. Economic analyses were not reported in the included studies, however, cost effectiveness information is needed in the field of antidepressant trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M. H., Freemantle, N., Boynton, J. R., Churchill, R. C., Eccles, M., Geddes, J. R., Hardy, R., Lewis, G., & Mason, J. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 87
Self-citationRetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
Diagnostic Criteria for Use in Psychiatric Research
Feighner, J. P. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,715
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702
(1994) · Medical Entomology and Zoology · Cited by 4,156
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
The Whoqol Group (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00009-4 · Cited by 3,802
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Self-citationPsychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Imputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568
Self-citationThe Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
Statistics Notes: Detecting skewness from summary information: Table 1
Altman, D. G., & Bland, J. M. (1996) · BMJ · doi:10.1136/bmj.313.7066.1200 · Cited by 1,278
Health of the Nation Outcome Scales (HoNOS): Research and development
Wing, J. K., Beevor, A. S., Curtis, R. H., Park, S. G. B., Hadden, J., & Burns, A. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.11 · Cited by 1,203
Global Assessment of Functioning
Hall, R. C. W. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71666-8 · Cited by 975
Distributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Cha, M., Eastwaad, S., Hartan, R., Maher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. L., & Straup, D. F. (1996) · Cited by 737
Eyding, D., Lelgemann, M., Grouven, U., Harter, M., Kromp, M., Kaiser, T., Kerekes, M. F., Gerken, M., & Wieseler, B. (2010) · BMJ · doi:10.1136/bmj.c4737 · Cited by 588
Bhandari, M., Busse, J. W., Jackowski, D., Montori, V. M., Schünemann, H. J., Sprague, S., Mears, D., Schemitsch, E. H., Heels-Ansdell, D., & Devereaux, P. J. (2004) · Europe PMC (PubMed Central) · Cited by 551
Mechanism of action of serotonin selective reuptake inhibitors
Stahl, S. M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00221-3 · Cited by 540
Smith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.396 · Cited by 538
St John's wort for major depression
Linde, K., Berner, M. M., & Kriston, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000448.pub3 · Cited by 477
Clinicians' Judgments of Mental Health: A Proposed Scale
LUBORSKY, L. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01720060019002 · Cited by 459
Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.168 · Cited by 429
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00011 · Cited by 423
Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1217 · Cited by 406
Nyth, A. L., & Gottfries, C. G. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.6.894 · Cited by 379
McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.001 · Cited by 365
Fava, M., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Alpert, J. E., McGrath, P. J., Thase, M. E., Warden, D., Biggs, M., Luther, J. F., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1161 · Cited by 362
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K., Lux, L., Van Noord, M., Mager, U., Thieda, P., Gaynes, B. N., Wilkins, T., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00009 · Cited by 355
Robinson, R. G., Jorge, R. E., Moser, D. J., Acion, L., Solodkin, A., Small, S. L., Fonzetti, P., Hegel, M., & Arndt, S. (2008) · JAMA · doi:10.1001/jama.299.20.2391 · Cited by 355
Arroll, B. (2005) · The Annals of Family Medicine · doi:10.1370/afm.349 · Cited by 351
Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients
Burke, W. J., Gergel, I., & Bose, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0410 · Cited by 350
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Uher, R., Perroud, N., Ng, M. Y. M., Hauser, J., Henigsberg, N., Maier, W., Mors, O., Placentino, A., Rietschel, M., Souery, D., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09070932 · Cited by 350
Meyer, J. H., Wilson, A. A., Ginovart, N., Goulding, V., Hussey, D., Hood, K., & Houle, S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1843 · Cited by 340
Imputing response rates from means and standard deviations in meta-analyses
Furukawa, T. A., Cipriani, A., Barbui, C., Brambilla, P., & Watanabe, N. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00010 · Cited by 337
Self-citationPerlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Furukawa, T. A., Guyatt, G. H., & Griffith, L. E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.72 · Cited by 318
Self-citationSertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub2 · Cited by 305
Self-citationCitalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
Gram, L. (1986) · Psychopharmacology · doi:10.1007/bf00172884 · Cited by 301
Sertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 299
Self-citationAntidepressants for depressed elderly
Mottram, P. G., Wilson, K., & Strobl, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003491.pub2 · Cited by 287
Müller, M. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00120-9 · Cited by 282
Prevalence, nature, and comorbidity of depressive disorders in primary care
Coyne, J. C., Fechner-Bates, S., & Schwenk, T. L. (1994) · General Hospital Psychiatry · doi:10.1016/0163-8343(94)90006-x · Cited by 281
Bollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.297 · Cited by 274
Devos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., Destée, A., Bordet, R., & Defebvre, L. (2008) · Movement Disorders · doi:10.1002/mds.21966 · Cited by 274
Hansen, R. A., Gartlehner, G., Lohr, K. N., Gaynes, B. N., & Carey, T. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-6-200509200-00006 · Cited by 255
Lepola, U. M., Loft, H., & Reines, E. H. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000074988.54339.7c · Cited by 254
Fluoxetine versus other types of pharmacotherapy for depression
Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 252
Self-citationEscitalopram versus citalopram: the surprising role of the R-enantiomer
S�nchez, C., B�ges�, K., Ebert, B., Reines, E., & Braestrup, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1865-z · Cited by 248
(2003) · PubMed · Cited by 236
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.007 · Cited by 229
Wisniewski, S. R., Rush, A. J., Nierenberg, A. A., Gaynes, B. N., Warden, D., Luther, J. F., McGrath, P. J., Lavori, P. W., Thase, M. E., Fava, M., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08071027 · Cited by 223
Frances, R. J. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70411-0 · Cited by 220
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R., & Furukawa, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114.pub2 · Cited by 209
Self-citationHandbook of assessment and treatment planning for psychological disorders.
Antony, M. M., & Barlow, D. H. (2002) · Guilford Press eBooks · Cited by 202
Fantino, B., & Moore, N. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-26 · Cited by 200
Roose, S. P., Sackeim, H. A., Krishnan, K. R. R., Pollock, B. G., Alexopoulos, G., Lavretsky, H., Katz, I. R., Hakkarainen, H., & Old-Old Depression Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2050 · Cited by 191
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190
Self-citationBhagwagar, Z., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.166 · Cited by 189
MUÑOZ, R. A. (2002) · American Journal of Psychiatry · doi:10.1176/ajp.159.6.1066 · Cited by 189
Moore, N., Verdoux, H., & Fantino, B. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200505000-00002 · Cited by 188
Leuchter, A. F., Cook, I. A., Marangell, L. B., Gilmer, W. S., Burgoyne, K. S., Howland, R. H., Trivedi, M. H., Zisook, S., Jain, R., McCracken, J. T., et al. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.06.004 · Cited by 177
Rush, A. J., Wisniewski, S. R., Warden, D., Luther, J. F., Davis, L. L., Fava, M., Nierenberg, A. A., & Trivedi, M. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.8.870 · Cited by 176
Moret, C., Charveron, M., Finberg, J. P. M., Couzinier, J. P., & Briley, M. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90157-1 · Cited by 172
Multicenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression
Feighner, J. P., & Overø, K. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1204 · Cited by 168
The economic burden of depression in the US: societal and patient perspectives
Greenberg, P. E., & Birnbaum, H. G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.369 · Cited by 166
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 165
Self-citationAcute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity
Bigos, K. L., Pollock, B. G., Aizenstein, H. J., Fisher, P. M., Bies, R. R., & Hariri, A. R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.52 · Cited by 164
Swartz, H. A., Frank, E., Zuckoff, A., Cyranowski, J. M., Houck, P. R., Cheng, Y., Fleming, M. A. D., Grote, N. K., Brent, D. A., & Shear, M. K. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07081339 · Cited by 164
Soares, C. N., Arsenio, H., Joffe, H., Bankier, B., Cassano, P., Petrillo, L. F., & Cohen, L. S. (2006) · Menopause · doi:10.1097/01.gme.0000240633.46300.fa · Cited by 164
Herrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Guzmán, D., Guàrdia-Olmos, J., Hinojosa-Calvo, E., & Herrera-Abarca, J. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.015 · Cited by 160
Khan, A., Khan, S. R., Walens, G., Kolts, R., & Giller, E. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300059 · Cited by 158
Furukawa, T. A., McGuire, H., & Barbui, C. (2002) · BMJ · doi:10.1136/bmj.325.7371.991 · Cited by 157
Self-citationModeration of antidepressant response by the serotonin transporter gene
Huezo-Diaz, P., Uher, R., Smith, R. G., Rietschel, M., Henigsberg, N., Marušiˇ, A., Mors, O. N., Maier, W., Hauser, J., Souery, D., et al. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.062521 · Cited by 149
Berlanga, C., & Flores‐Ramos, M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.04.029 · Cited by 149
Opbroek, A., Delgado, P. L., Laukes, C., McGahuey, C., Katsanis, J., Moreno, F. A., & Manber, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002870 · Cited by 147
Leinonen, E., Skarstein, J., Behnke, K., ??gren, H., & Th Helsdingen, J. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199911000-00002 · Cited by 146
Response Inhibition Predicts Poor Antidepressant Treatment Response in Very Old Depressed Patients
Sneed, J. R., Roose, S. P., Keilp, J. G., Krishnan, K. R. R., Alexopoulos, G. S., & Sackeim, H. A. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180302513 · Cited by 146
Stahl, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00957-4 · Cited by 134
Milnacipran, a new serotonin and noradrenaline reuptake inhibitor
Puech, A. J., Montgomery, S., Prost, J. F., Solles, A., & Briley, M. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199703000-00005 · Cited by 134
Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
Buchkowsky, S. S., & Jewesson, P. J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d267 · Cited by 132
Juckel, G., Pogarell, O. M., Augustin, H., Mulert, C., Muller-Siecheneder, F., Frodl, T., Mavrogiorgou, P., & Hegerl, U. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0806 · Cited by 126
Dozois, D. J. A., Bieling, P., Patelis‐Siotis, I., Hoar, L., Chudzik, S., McCabe, K. M., & Westra, H. A. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0016886 · Cited by 126
Handbook of Assessment and Treatment Planning for Psychological Disorders
Rutter, M. E. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.5.757 · Cited by 126
Depression in idiopathic Parkinson's disease treated with citalopram: A placebo-controlled trial
Wermuth, L., Sørensen, P. S., Timm, S., Christensen, B., Utzon, N. P., Boas, J., Dupont, E., Hansen, E., Magnussen, I., Mikkelsen, B. O., et al. (1998) · Nordic Journal of Psychiatry · doi:10.1080/08039489850139049 · Cited by 126
Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder
Dell’Osso, B. M., Hadley, S. J., Allen, A., Baker, B. R., Chaplin, W. F., & Hollander, E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0316 · Cited by 120
SSRIs Do Not Worsen Parkinson's Disease: Evidence from an Open-Label, Prospective Study
Dell’Agnello, G., Ceravolo, R., Nuti, A., Bellini, G., Piccinni, A., D’Avino, C., Dell’Osso, L., & Bonuccelli, U. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200107000-00005 · Cited by 119
Muhonen, L. H., Lönnqvist, J. K., Juva, K., & Alho, H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0308 · Cited by 118
Kraus, M. R., Schäfer, A., Schöttker, K., Keicher, C., Weißbrich, B., Hofbauer, I., & Scheurlen, M. (2007) · Gut · doi:10.1136/gut.2007.131607 · Cited by 118
Montgomery, J. H., Byerly, M., Carmody, T. J., Li, B., Miller, D. R., Varghese, F. P., & Holland, R. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.09.002 · Cited by 117
Allard, P. O., Gram, L. F., Timdahl, K., Behnke, K., Hanson, M., & Søgaard, J. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1190 · Cited by 117
Kühn, K.-U., Quednow, B. B., Thiel, M., Falkai, P., Maier, W., & Elger, C. E. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.08.009 · Cited by 117
Lydiatt, W. M., Denman, D., McNeilly, D. P., Puumula, S. E., & Burke, W. J. (2008) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.134.5.528 · Cited by 108
McGrath, P. J., Khan, A. Y., Trivedi, M. H., Stewart, J. W., Morris, D. W., Wisniewski, S. R., Miyahara, S., Nierenberg, A. A., D, M. F. M., & Rush, A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1201 · Cited by 107
Sildenafil as Treatment for Antidepressant-Induced Sexual Dysfunction—Reply
Nurnberg, H. G. (2008) · JAMA · doi:10.1001/jama.2008.694 · Cited by 103
Davis, L. L., Frazier, E. C., Husain, M. M., Warden, D., Trivedi, M. H., D, M. F. M., Cassano, P., McGrath, P. J., Balasubramani, G. K., Wisniewski, S. R., et al. (2006) · American Journal on Addictions · doi:10.1080/10550490600754317 · Cited by 103
Suicide, depression, and antidepressants
Cipriani, A., Barbui, C., & Geddes, J. R. (2005) · BMJ · doi:10.1136/bmj.330.7488.373 · Cited by 102
Self-citationKiosses, D. N., Areán, P. A., Teri, L. L., & Alexopoulos, G. S. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181d6947d · Cited by 102
Sharp, D., Chew-Graham, C. A., Tylee, A. T., Lewis, G., Howard, L. M., Anderson, I. M., Abel, K. M., Turner, K. M., Hollinghurst, S., Tallon, D., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14430 · Cited by 102
Hochstrasser, B., Pm, I., Koponen, H., Lauritzen, L., Mahnert, F. A., Rouillon, F., Wade, A. G., Andersen, M. Ø., Pedersen, S. F., Swart, J. C. G. D., et al. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.4.304 · Cited by 101
Pae, C., Forbes, A., & Patkar, A. A. (2010) · CNS Drugs · doi:10.2165/11538980-000000000-00000 · Cited by 99
Stahl, S. M. (1994) · PubMed · Cited by 99
Thase, M. E., Nierenberg, A. A., Vrijland, P., van Oers, H. J. J., Schutte, A. J., & Simmons, J. H. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328330adb2 · Cited by 96
Citalopram reduces endotoxin-induced fatigue
Hannestad, J., DellaGioia, N., Ortiz, N., Pittman, B., & Bhagwagar, Z. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.013 · Cited by 95
Kyle, C. J., Petersen, H. E. H., & Over�, K. F. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:4<147::aid-da3>3.0.co;2-f · Cited by 94
Change in Cognitive Functioning Following Acute Antidepressant Treatment in Late-Life Depression
Culang, M. E., Sneed, J. R., Keilp, J. G., Rutherford, B. R., Pelton, G. H., Devanand, D. P., & Roose, S. P. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b4bf4a · Cited by 94
Bauer, M., El-Khalili, N., Datto, C. J., Szamosi, J., & Eriksson, H. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.032 · Cited by 92
Ekselius, L., von Knorring, L., & Eberhard, G. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199711000-00005 · Cited by 92
Lepola, U. M., Wade, A. G., & Andersen, H. F. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00005 · Cited by 91
Gastpar, M., Singer, A., & Zeller, K. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931544 · Cited by 90
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium
Dorée, J.-P., Rosiers, J. D., Lew, V., Gendron, A., Elie, R., Stip, É., & Tourjman, V. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x162809 · Cited by 90
Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder
Gorwood, P. A. P. M., Weiller, E., Lemming, O. M., & Katona, C. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000240823.94522.4c · Cited by 89
Evidence-Based Guidelines for Interpretation of the Hamilton Rating Scale for Depression
Furukawa, T. A., Akechi, T., Azuma, H., Okuyama, T., & Higuchi, T. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31814f30b1 · Cited by 89
Self-citationPrediction of the response to citalopram and reboxetine in post-stroke depressed patients
Rampello, L., Chiechio, S., Nicoletti, G. F., Alvano, A., Vecchio, I., Raffaele, R., & Malaguarnera, M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1698-1 · Cited by 87
Davis, L. L., Wisniewski, S. R., Howland, R. H., Trivedi, M. H., Husain, M. M., D, M. F. M., McGrath, P. J., Balasubramani, G. K., Warden, D., & Rush, A. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.003 · Cited by 87
Are we going to increase the use of antidepressants up to that of benzodiazepines?
Ciuna, A., Andretta, M., Corbari, L., Levi, D., Mirandola, M., Sorio, A., & Barbui, C. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0810-8 · Cited by 87
Self-citationAntidepressant Drug Consumption and Public Health Indicators in Italy, 1955 to 2000
Guaiana, G., Andretta, M., Corbari, L., Mirandola, M., Sorio, A., D’Avanzo, B., & Barbui, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0612 · Cited by 86
Self-citationPatris, M., Bouchard, J. M., Bougerol, T., Jf, C., Chevalier, J.-F., Clerc, G., Cyran, C., Amerongen, P. V., Lemming, O. M., & Petersen, H. E. H. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606000-00007 · Cited by 85
The Indiana Cancer Pain and Depression (INCPAD) trial
Kroenke, K., Theobald, D., Norton, K., Sanders, R., Schlundt, S., McCalley, S., Harvey, P., Iseminger, K. A., Morrison, G. C., Carpenter, J. S., et al. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.01.007 · Cited by 84
Perlis, R. H., Fijal, B. A., Adams, D. H., Sutton, V. K., Trivedi, M. H., & Houston, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.002 · Cited by 84
Hindmarch, I., Kimber, S., & Cockle, S. M. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015060-00001 · Cited by 84
Angermann, C. E., Gelbrich, G., Störk, S., Fallgatter, A. J., Deckert, J., Faller, H., & Ertl, G. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.10.005 · Cited by 84
Serfaty, M. A., Osborne, D., Buszewicz, M., Blizard, R., & Raven, P. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832c260b · Cited by 82
Colonna, L., Andersen, H. F., & Reines, E. H. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x65484 · Cited by 82
Preclinical pharmacology of milnacipran
Briley, M., Prost, J. F., & Moret, C. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199609004-00002 · Cited by 81
What predicts attrition in second step medication treatments for depression?: a STAR*D Report
Warden, D., Rush, A. J., Wisniewski, S. R., Lesser, I. M., Kornstein, S. G., Balasubramani, G. K., Thase, M. E., Preskorn, S., Nierenberg, A. A., Young, E. A., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009073 · Cited by 79
Sneed, J. R., Culang‐Reinlieb, M. E., Keilp, J. G., Rutherford, B. R., Devanand, D. P., & Roose, S. P. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181c796d2 · Cited by 75
Karlsson, I., Godderis, J., Lima, C. A. D. M., Nygaard, H. A., Sim�nyi, M., Taal, M., & Eglin, M. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200004)15:4<295::aid-gps105>3.0.co;2-c · Cited by 75
Baldwin, D. S., Bridgman, K. M., & Buis, C. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105056666 · Cited by 74
Milnacipran: A Review of its Use in Depression
Spencer, C. M., & Wilde, M. I. (1998) · Drugs · doi:10.2165/00003495-199856030-00010 · Cited by 73
Berney, A., Nishikawa, M., Benkelfat, C., Debonnel, G., Gobbi, G., & Dikšić, M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.08.021 · Cited by 72
Yevtushenko, V. Y., Belous, A., Yevtushenko, Y. G., Gusinin, S. E., Buzik, O. Z., & Agibalova, T. V. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.11.014 · Cited by 71
Lavretsky, H., Siddarth, P., & Irwin, M. R. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181beab1e · Cited by 71
Depression and Alzheimer's disease: Symptom or comorbidity?
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700607 · Cited by 70
Rapaport, M. H., Nierenberg, A. A., Howland, R. H., Dording, C. M., Schettler, P. J., & Mischoulon, D. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.05.001 · Cited by 70
Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder
Stein, D. J., Montgomery, S., Kasper, S. F., & Tanghøj, P. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200111000-00007 · Cited by 70
The citalopram challenge test in patients with major depression and in healthy controls
Kapitany, T., Schindl, M., Schindler, S. D., Heßelmann, B., Füreder, T., Barnas, C., Sieghart, W., & Kasper, S. F. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00082-7 · Cited by 69
Citalopram versus nortriptyline in late‐life depression: a 12‐week randomized single‐blind study
Navarro, V., Gastó, C., Torres, X., Marcos, T., & Pintor, L. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00228.x · Cited by 69
van Bemmel, A. L., van den Hoofdakker, R. H., Beersma, D. G. M., & Bouhuys, A. L. (1993) · Psychopharmacology · doi:10.1007/bf02245702 · Cited by 68
Garriock, H. A., Tanowitz, M., Kraft, J. B., Dang, V. C., Peters, E. J., Jenkins, G. D., Reinalda, M. S., McGrath, P. J., von Zastrow, M., Slager, S. L., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08081167 · Cited by 68
Are All Antidepressants Really the Same? The Case of Fluoxetine: A Systematic Review
Cipriani, A., Barbui, C., Brambilla, P., Furukawa, T. A., Hotopf, M. H., & Geddes, J. R. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0601 · Cited by 68
Self-citationTreatment of depressive symptoms in Parkinson’s disease
Barone, P. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03325.x · Cited by 68
Clerc, G. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200105000-00003 · Cited by 67
Martiny, K., Lunde, M., Simonsen, C., Clemmensen, L., Poulsen, D. L., Solstad, K., & Bech, P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.1600-0447.2003.00256.x · Cited by 64
Portella, M. J., de Diego-Adeliño, J., Ballesteros, J., Puigdemont, D., Oller, S., Santos, B., Álvarez, E., Artigas, F., & Pérez, V. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05827blu · Cited by 63
"Wish Bias" in Antidepressant Drug Trials?
Barbui, C., Cipriani, A., Brambilla, P., & Hotopf, M. H. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000115665.45074.0d · Cited by 63
Self-citationCourt, A., Mulder, C., Kerr, M., Yuen, H. P., Boasman, M., Goldstone, S. D., Fleming, J., Weigall, S., Derham, H., Huang, C., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.011 · Cited by 63
Fernández, J., Montgomery, S., & Francois, C. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523020-00007 · Cited by 63
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
Amiaz, R., Fostick, L., Gershon, A. A., & Zohar, J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.006 · Cited by 61
Kornstein, S. G., Bose, A., Li, D., Saikali, K. G., & Gandhi, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1115 · Cited by 60
Wilde, J. E. D., Mertens, C., Overø, K. F., & Petersen, H. E. H. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb02576.x · Cited by 59
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial
Lewis, G., Mulligan, J., Wiles, N., Cowen, P. J., Craddock, N. J., Ikeda, M., Grozeva, D., Mason, V. L., Nutt, D., Sharp, D., et al. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.082727 · Cited by 59
Miskowiak, K. W., Favaron, E., Hafizi, S., Inkster, B., Goodwin, G. M., Cowen, P. J., & Harmer, C. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1641-1 · Cited by 58
Rosenberg, C., Damsbo, N., Fuglum, E., Jacobsen, L. V., & Horsgård, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00007 · Cited by 58
Rocca, P., Calvarese, P., Faggiano, F., Marchiaro, L., Mathis, F., Rivoira, E., Taricco, B., & Bogetto, F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0313 · Cited by 58
Suh, T., & Gallo, J. J. (1997) · Psychological Medicine · doi:10.1017/s0033291797005205 · Cited by 58
Soares, C. N., Thase, M. E., Clayton, A. H., Guico‐Pabia, C. J., Focht, K., Jiang, Q. L., Kornstein, S. G., Ninan, P. T., Kane, C. P., & Cohen, L. S. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181d88962 · Cited by 57
Procyshyn, R. M., Chau, A. M. T., Fortin, P. M., & Jenkins, W. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900905 · Cited by 57
Rampello, L., Alvano, A., Chiechio, S., Malaguarnera, M., Raffaele, R., Vecchio, I., & Nicoletti, F. (2004) · Neuropsychobiology · doi:10.1159/000080960 · Cited by 56
Guelfi, J., Ansseau, M., Corruble, E., Samuelian, J., Tonelli, I., Tournoux, A., & Plétan, Y. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199805000-00005 · Cited by 56
Milnacipran versus other antidepressive agents for depression
Nakagawa, A., Watanabe, N., Omori, I. M., Barbui, C., Cipriani, A., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006529.pub2 · Cited by 55
Self-citationBjerkenstedt, L., Edman, G., Flyckt, L., Hagenfeldt, L., Sedvall, G., & Wiesel, F. ‐. (1985) · Psychopharmacology · doi:10.1007/bf00432703 · Cited by 55
Amitriptyline versus other types of pharmacotherapy for depression
Guaiana, G., Barbui, C., & Hotopf, M. H. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004186 · Cited by 54
Self-citationMRI subcortical hyperintensities in old and very old depressed outpatients
Salloway, S., Correia, S., Boyle, P. A., Malloy, P., Schneider, L. S. S., Lavretsky, H., Sackheim, H. A., Roose, S. P., & Krishnan, K. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00296-4 · Cited by 54
Fráguas, R., Telles, R. M. S., Alves, T. C. T. F., Andrei, A. M., Rays, J., Iosifescu, D. V., & Wajngarten, M. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.01.007 · Cited by 53
Morasco, B. J., Loftis, J. M., Indest, D. W., Ruimy, S., Davison, J. W., Felker, B. L., & Hauser, P. (2010) · Psychosomatics · doi:10.1176/appi.psy.51.5.401 · Cited by 53
Tignol, J.-P., Pujol‐Domenech, J., Chartres, J. P., Jm, L., Plétan, Y., Tonelli, I., Tournoux, A., & Pezous, N. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb09980.x · Cited by 52
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression
DeBattista, C., Kinrys, G., Hoffman, D. A., Goldstein, C., Zajecka, J., Kocsis, J. H., Teicher, M. H., Potkin, S. G., Preda, A., Multani, G., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.05.009 · Cited by 51
Holtzheimer, P. E., Meeks, T. W., Kelley, M. E., Mufti, M., Young, R., McWhorter, K., Vito, N., Chismar, R., Quinn, S., Dey, S., et al. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1951 · Cited by 50
Catena, F., Ansaloni, L., Saverio, S. D., Gazzotti, F., GAGLIARDI, S., Coccolini, F., D'Alessandro, L., Ercolani, G., Talarico, C. A., Bassi, U. A., et al. (2008) · Trials · doi:10.1186/1745-6215-9-1 · Cited by 49
Anderer, P., Saletu, B., Semlitsch, H. V., & Pascual-Marqui, R. D. (2002) · PubMed · Cited by 49
A comparative study of milnacipran and paroxetine in outpatients with major depression
Sechter, D., Vandel, P., Weiller, E., Pezous, N., Cabanac, F., & Tournoux, A. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.07.002 · Cited by 48
Souery, D., Serretti, A., Calati, R., Oswald, P., Massat, I., Konstantinidis, A., Linotte, S., Kasper, S. F., Montgomery, S., Zohar, J., et al. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.590225 · Cited by 48
Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?
Gilmer, W. S., Gollan, J. K., Wisniewski, S. R., Howland, R. H., Trivedi, M. H., Miyahara, S., Fleck, J., Thase, M. E., Alpert, J. E., Nierenberg, A. A., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0807 · Cited by 46
Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patients
Bouchard, J. M., Delaunay, J., Delisle, J. ‐., Grasset, N., Mermberg, P. F., Molczadzki, M., Pagot, R., Richou, H., Robert, G., Ropert, R., et al. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02923.x · Cited by 46
Traitement des épisodes dépressifs sévères : escitalopram est plus efficace que citalopram
Azorin, J., Llorca, P., Despiégel, N., & Verpillat, P. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95427-9 · Cited by 46
Zisook, S., Kasckow, J. W., Lanouette, N. M., Golshan, S., Fellows, I., Vahia, I., Mohamed, S., & Rao, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05699gre · Cited by 45
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Sertraline versus other antidepressive agents for depression
Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 299
Self-citationNewer generation antidepressants for depressive disorders in children and adolescents
Hetrick, S. E., McKenzie, J. E., Cox, G. R., Simmons, M. B., & Merry, S. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004851.pub3 · Cited by 291
Turrini, G., Purgato, M., Acarturk, C., Anttila, M., Au, T., Ballette, F., Bird, M., Carswell, K., Churchill, R., Cuijpers, P., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000027 · Cited by 258
Self-citationFluoxetine versus other types of pharmacotherapy for depression
Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 252
Self-citation
Metadata
- Authors
- Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-07-11
- Volume
- 2012
- Issue
- 7
- Pages
- CD006534-CD006534
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2100278846
- Cited by
- 311
- References
- 313
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.